Date of Acceptance: 15/01/2015 Copyright © 2015, American Association for Cancer Research. Acknowledgements We would like to thank the following people for their contributions to the manuscript: David Castenson (Information Management Services, Calverton MD, USA); Dana Mates (Institute of Public Health, Bucharest, Romania); Vladimir Bencko (Charles University in Prague, Czech Republic); Victor Wünsch-Filho (School of Public Health, University of Sao Paulo, Sao Paulo, Brazil); Elena Matos(Institute of Oncology Angel H. Roffo, University of Buenos Aires, Buenos Aires, Argentina); and Jose Eluf-Neto (Universidade de São Paulo, Sao Paulo, Brazil). We acknowledge contribution of Professor Gary J Macfarlane, Dr Ann-Marie Biggs, Professor Martin T...
Global data on human papillomavirus serological and DNA prevalence are essential to optimize HPV pro...
A thesis submitted to the University of Luton for the degree of Doctor of PhilosophyHigh-risk mucosa...
Abstract Purpose: Human papillomavirus-16 (HPV16) is the causative agent in a biologically distinct ...
Background: The increasing incidence of oropharyngeal cancer in many developed countries has been at...
BACKGROUND: The increasing incidence of oropharyngeal cancer in many developed countries has been at...
© 2015 AACR. Background: The increasing incidence of oropharyngeal cancer in many developed countri...
Background: Human papillomavirus type 16 (HPV16)-E6 antibodies are detectable in peripheral blood be...
Background: The increasing incidence of oropharyngeal cancer in many developed countries has been at...
Purpose: Human papillomavirus (HPV) type 16 (HPV16) causes cancer at several anatomic sites. In the ...
Funding information: This project was funded in part by NIH/NIDCR R01 DE025712 (Paul Brennan, Brenda...
Background Antibodies against the HPV16 oncoprotein E6 are promising biomarkers for HPV16-driven oro...
Funding Information: This study is part of an NIDCR funded project called VOYAGER (R01DE025712) with...
Funding Information: The authors would like to thank the Riga Stradi?? University Department of Doct...
Introduction:This review investigates the role of p16INK4a as a marker of transcriptionally active h...
IntroductionHuman papillomavirus 16 (HPV16) is the main cause of oropharyngeal squamous cell carcino...
Global data on human papillomavirus serological and DNA prevalence are essential to optimize HPV pro...
A thesis submitted to the University of Luton for the degree of Doctor of PhilosophyHigh-risk mucosa...
Abstract Purpose: Human papillomavirus-16 (HPV16) is the causative agent in a biologically distinct ...
Background: The increasing incidence of oropharyngeal cancer in many developed countries has been at...
BACKGROUND: The increasing incidence of oropharyngeal cancer in many developed countries has been at...
© 2015 AACR. Background: The increasing incidence of oropharyngeal cancer in many developed countri...
Background: Human papillomavirus type 16 (HPV16)-E6 antibodies are detectable in peripheral blood be...
Background: The increasing incidence of oropharyngeal cancer in many developed countries has been at...
Purpose: Human papillomavirus (HPV) type 16 (HPV16) causes cancer at several anatomic sites. In the ...
Funding information: This project was funded in part by NIH/NIDCR R01 DE025712 (Paul Brennan, Brenda...
Background Antibodies against the HPV16 oncoprotein E6 are promising biomarkers for HPV16-driven oro...
Funding Information: This study is part of an NIDCR funded project called VOYAGER (R01DE025712) with...
Funding Information: The authors would like to thank the Riga Stradi?? University Department of Doct...
Introduction:This review investigates the role of p16INK4a as a marker of transcriptionally active h...
IntroductionHuman papillomavirus 16 (HPV16) is the main cause of oropharyngeal squamous cell carcino...
Global data on human papillomavirus serological and DNA prevalence are essential to optimize HPV pro...
A thesis submitted to the University of Luton for the degree of Doctor of PhilosophyHigh-risk mucosa...
Abstract Purpose: Human papillomavirus-16 (HPV16) is the causative agent in a biologically distinct ...